VHCP Management II, LLC
data from 31/12/2019
Capitalization
$ 379.352 M
44.57 %
Performance
$ 347.548 M
123.42 %
| Date | Ticket | Name | Weight | Capitalization | Share number | First added | Performance ($) | Performance (%) |
|---|---|---|---|---|---|---|---|---|
| 2019/12/31 | TXG | 10X Genomics Inc. | 35.91% | 136.215 M $ | 1786431 | 2019/09/30 | 46.179 M $ | 51.29 % |
| 2019/12/31 | AXSM | Axsome Therapeutics Inc | 21.42% | 81.239 M $ | 785981 | 2019/03/31 | 74.222 M $ | 410.68 % |
| 2019/12/31 | CNST | Constellation Pharmaceuticals | 18.64% | 70.695 M $ | 1500631 | 2018/09/30 | 29.539 M $ | 629.30 % |
| 2019/12/31 | BHVN | Biohaven Pharmaceuticals | 6.64% | 25.200 M $ | 462903 | 2017/06/30 | 0.000 $ | 0.00 % |
| 2019/12/31 | SWAV | Shockwave Medical Inc | 3.34% | 12.686 M $ | 288838 | 2019/03/31 | 9.044 M $ | 46.74 % |
| 2019/12/31 | ISEE | Iveric Bio Inc | 2.27% | 8.617 M $ | 1004299 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | KALV | Kalvista Pharmaceuticals | 1.72% | 6.523 M $ | 366268 | 2018/09/30 | 2.340 M $ | 53.53 % |
| 2019/12/31 | OBSV | Obseva SA | 1.58% | 6.011 M $ | 1573639 | 2017/06/30 | -10.159 M $ | -54.14 % |
| 2019/12/31 | MRSN | Mersana Therapeutics Inc | 1.39% | 5.286 M $ | 922514 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | SPRO | Spero Therapeutics Inc | 1.20% | 4.558 M $ | 474015 | 2017/12/31 | -466.904 K $ | -9.29 % |
| 2019/12/31 | RLMD | Relmada Therapeutics Inc | 1.18% | 4.480 M $ | 114876 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | ADVM | Adverum Biotechnologies Inc | 1.16% | 4.419 M $ | 383620 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | Marinus Pharmaceuticals Inc | 0.85% | 3.211 M $ | 1486676 | 2018/06/30 | 921.739 K $ | 40.27 % | |
| 2019/12/31 | Forty Seven Inc | 0.81% | 3.060 M $ | 77714 | 2019/12/31 | 0.000 $ | 0.00 % | |
| 2019/12/31 | MIST | Milestone Pharmaceuticals Inc | 0.63% | 2.378 M $ | 148560 | 2019/06/30 | -392.198 K $ | -14.15 % |
| 2019/12/31 | NXTC | Nextcure Inc | 0.54% | 2.042 M $ | 36249 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | MYOV | Myovant Sciences Ltd | 0.31% | 1.191 M $ | 76768 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | ETNB | 89Bio Inc | 0.29% | 1.084 M $ | 41235 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | Bellerophon Therapeutics | 0.06% | 230.000 K $ | 659087 | 2017/09/30 | -551.991 K $ | -27.60 % | |
| 2019/12/31 | PTGX | Protagonist Therapeutics Inc | 0.06% | 227.000 K $ | 32211 | 2018/12/31 | -2.117 M $ | -41.30 % |
| 2019/12/31 | TCDA | Tricida Inc | 0.00% | 0.000 $ | 0 | 2018/06/30 | 0.000 $ | 0.00 % |
| 2019/12/31 | Prevail Therapeutics Inc | 0.00% | 0.000 $ | 0 | 2019/09/30 | 0.000 $ | 0.00 % | |
| 2019/12/31 | ASND | Ascendis Pharma A/S | 0.00% | 0.000 $ | 0 | 2015/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | RARX | Ra Pharmaceuticals | 0.00% | 0.000 $ | 0 | 2016/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | LJPC | La Jolla Pharmaceuticals | 0.00% | 0.000 $ | 0 | 2019/03/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | RDUS | Radius Health Inc | 0.00% | 0.000 $ | 0 | 2019/09/30 | 0.000 $ | 0.00 % |
| 2019/12/31 | Proteostasis Therapeutics Inc | 0.00% | 0.000 $ | 0 | 2018/12/31 | 0.000 $ | 0.00 % | |
| 2019/12/31 | KNSA | Kiniksa Pharmaceuticals Ltd | 0.00% | 0.000 $ | 0 | 2018/06/30 | 0.000 $ | 0.00 % |
| 2019/12/31 | BCRX | BioCryst Pharmaceuticals Inc | 0.00% | 0.000 $ | 0 | 2016/03/31 | 0.000 $ | 0.00 % |